Literature DB >> 34057091

Life Course Adiposity and Alzheimer's Disease: A Mendelian Randomization Study.

Xian Li1, Yan Tian2, Yu-Xiang Yang3, Ya-Hui Ma2, Xue-Ning Shen3, Shi-Dong Chen3, Prof Qiang Dong3, Lan Tan1,2, Jin-Tai Yu3.   

Abstract

BACKGROUND: Several studies showed that life course adiposity was associated with Alzheimer's disease (AD). However, the underlying causality remains unclear.
OBJECTIVE: We aimed to examine the causal relationship between life course adiposity and AD using Mendelian randomization (MR) analysis.
METHODS: Instrumental variants were obtained from large genome-wide association studies (GWAS) for life course adiposity, including birth weight (BW), childhood body mass index (BMI), adult BMI, waist circumference (WC), waist-to-hip ratio (WHR), and body fat percentage (BFP). A meta-analysis of GWAS for AD including 71,880 cases and 383,378 controls was used in this study. MR analyses were performed using inverse variance weighted (IVW), weighted median, and MR-Egger regression methods. We calculated odds ratios (ORs) per genetically predicted standard deviation (1-SD) unit increase in each trait for AD.
RESULTS: Genetically predicted 1-SD increase in adult BMI was significantly associated with higher risk of AD (IVW: OR = 1.03, 95% confidence interval [CI] = 1.01-1.05, p = 2.7×10-3) after Bonferroni correction. The weighted median method indicated a significant association between BW and AD (OR = 0.94, 95% CI = 0.90-0.98, p = 1.8×10-3). We also found suggestive associations of AD with WC (IVW: OR = 1.03, 95% CI = 1.00-1.07, p = 0.048) and WHR (weighted median: OR = 1.04, 95% CI = 1.00-1.07, p = 0.029). No association was detected of AD with childhood BMI and BFP.
CONCLUSION: Our study demonstrated that lower BW and higher adult BMI had causal effects on increased AD risk.

Entities:  

Keywords:  Alzheimer’s disease; causal relations; life course adiposity; mendelian randomization

Year:  2021        PMID: 34057091     DOI: 10.3233/JAD-210345

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  1 in total

1.  Mendelian randomization highlights significant difference and genetic heterogeneity in clinically diagnosed Alzheimer's disease GWAS and self-report proxy phenotype GWAX.

Authors:  Haijie Liu; Yang Hu; Yan Zhang; Haihua Zhang; Shan Gao; Longcai Wang; Tao Wang; Zhifa Han; Bao-Liang Sun; Guiyou Liu
Journal:  Alzheimers Res Ther       Date:  2022-01-28       Impact factor: 6.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.